Seelos Therapeutics, Inc. - Company Profile
Powered by 
All the data and insights you need on Seelos Therapeutics, Inc. in one report.
$295
- Save hours of research time and resources with
our up-to-date Seelos Therapeutics, Inc. Strategy Report
- Understand Seelos Therapeutics, Inc. position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Seelos Therapeutics, Inc. Lead Sheet
Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Seelos Therapeutics, Inc.’s relevant decision makers and contact details.
A sample of Seelos Therapeutics, Inc. Lead Sheet data
| Lead Date | Lead Type | Lead Description | Company Name | Drug Name | Therapy Area |
|---|---|---|---|---|---|
| 16 Mar 2023 | GDCTWXYZ | Lorem | Lorem | Lorem | Cardiovascular |
| 16 Mar 2023 | Expected Trial Results | Phase II Results Expected in Q3-2023 | Acadia Healthcare Co Inc | ketamine hydrochloride | Central Nervous System |
| 10 Mar 2023 | Capital Raisings | Seelos Therapeutics to Raise USD11.24 Million in Registered Direct Offering of Common Stock and Warrants | Seelos Therapeutics, Inc. | (alprostadil + lidocaine hydrochloride); (betamethasone + calcipotriene); acetaminophen; alprostadil; aplindore fumarate; filgrastim; fluorouracil; insulin human; ketamine hydrochloride; lansoprazole; lidocaine hydrochloride; NM-02101; NM-02216; NM-100064; NM-100065; NM-100067; NM-100080; NM-100100; paclitaxel; rituximab NexACT; SLS-004; SLS-007; SLS-008; SLS-010; terbinafine hydrochloride; trehalose | Cardiovascular; Central Nervous System; Dermatology; Gastrointestinal; Genetic Disorders; Immunology; Infectious Disease; Male Health; Metabolic Disorders; Musculoskeletal Disorders; Oncology; Other Diseases; Respiratory; Toxicology; Undisclosed; Women's Health |
| 15 Feb 2023 | Expected Trial Initiations | Phase III Trial Initiation Expected on 01-Mar-2023 | Massachusetts General Hospital | trehalose | Central Nervous System |
Feature
Lead Sheet offers business development users in a Supplier Company, convenient access to leads within the biopharmaceutical industry.
- Lead: Any current or future events that signal a company may need services from another company in the near future.
Depending on the user’s company type, specific events may be considered a lead for the goods or services they provide.
Benefit
Leads within Lead Sheet fall into six major types of occurrences: Trial Events, Regulatory Events, Deals, Insights, New Companies, and Role Changes.
Some of these categories are broken out further to allow users the flexibility to filter to the event types they consider a lead.
Any lead type starting with “Expected” implies that it is a future event sourced from our Catalyst Calendar.
Value
Lead Sheet is a business development tool to help optimize sales efficiency
- What prospective accounts to target
- When and why to target them through actionable leads/opportunities
- Who to reach out to
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer